CP and systemic lupus erythematosus: The lower TVC in these samples resulted from the impacts of the combined treatments involving the PEF, which assists the efficiency of the antibacterial agents present in the SLE as well as the efficacy of the MAP or CP treatments on the viability of the mesophilic bacteria.